222 related articles for article (PubMed ID: 26233579)
1. The prognostic value of pSTAT3 in gastric cancer: a meta-analysis.
Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
J Cancer Res Clin Oncol; 2016 Mar; 142(3):649-57. PubMed ID: 26233579
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of E-cadherin in gastric cancer: a meta-analysis.
Xing X; Tang YB; Yuan G; Wang Y; Wang J; Yang Y; Chen M
Int J Cancer; 2013 Jun; 132(11):2589-96. PubMed ID: 23169395
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of STAT3/pSTAT3 was associated with poor prognosis in gastric cancer: a meta-analysis.
He S; Liao G; Liu Y; Huang L; Kang M; Chen L
Int J Clin Exp Med; 2015; 8(11):20014-23. PubMed ID: 26884913
[TBL] [Abstract][Full Text] [Related]
4. The prognostic impact of occult lymph node metastasis in node-negative gastric cancer: a systematic review and meta-analysis.
Huang JY; Xu YY; Li M; Sun Z; Zhu Z; Song YX; Miao ZF; Wu JH; Xu HM
Ann Surg Oncol; 2013 Nov; 20(12):3927-34. PubMed ID: 23892524
[TBL] [Abstract][Full Text] [Related]
5. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic and Clinicopathological Significance of Tumor-Associated Macrophages in Patients with Gastric Cancer: A Meta-Analysis.
Yin S; Huang J; Li Z; Zhang J; Luo J; Lu C; Xu H; Xu H
PLoS One; 2017; 12(1):e0170042. PubMed ID: 28081243
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancer.
Liu Y; Deng J; Luo X; Pan Y; Zhang L; Zhang R; Liang H
Med Oncol; 2015 Jan; 32(1):404. PubMed ID: 25471787
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis.
Soleyman-Jahi S; Nedjat S; Abdirad A; Hoorshad N; Heidari R; Zendehdel K
PLoS One; 2014; 10(4):e0122316. PubMed ID: 25919283
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value and Clinicopathological Significance of p-stat3 Among Gastric Carcinoma Patients: A Systematic Review and Meta-Analysis.
Ji K; Zhang L; Zhang M; Chu Q; Li X; Wang W
Medicine (Baltimore); 2016 Feb; 95(5):e2641. PubMed ID: 26844481
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 expression and patient survival in gastric cancer: a systematic review of the literature with meta-analysis.
Cheng H; Wang X; Li T; Chen L
Med Oncol; 2015 Jan; 32(1):389. PubMed ID: 25428392
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved.
Lu L; Wu M; Sun L; Li W; Fu W; Zhang X; Liu T
Medicine (Baltimore); 2016 Oct; 95(42):e5163. PubMed ID: 27759647
[TBL] [Abstract][Full Text] [Related]
12. Expression of chemokine receptor CCR7 is a negative prognostic factor for patients with gastric cancer: a meta-analysis.
Du P; Liu Y; Ren H; Zhao J; Zhang X; Patel R; Hu C; Gan J; Huang G
Gastric Cancer; 2017 Mar; 20(2):235-245. PubMed ID: 26984468
[TBL] [Abstract][Full Text] [Related]
13. The Role of p-STAT3 as a Prognostic and Clinicopathological Marker in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Ji K; Zhang M; Chu Q; Gan Y; Ren H; Zhang L; Wang L; Li X; Wang W
PLoS One; 2016; 11(8):e0160125. PubMed ID: 27504822
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of CD44 expression in gastric cancer: a meta-analysis.
Chen Y; Fu Z; Xu S; Xu Y; Xu P
Biomed Pharmacother; 2014 Jul; 68(6):693-7. PubMed ID: 25194445
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysis.
Lu L; Wu M; Zhao F; Fu W; Li W; Li X; Liu T
Oncotarget; 2016 Oct; 7(42):69087-69096. PubMed ID: 27634907
[TBL] [Abstract][Full Text] [Related]
16. Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma.
Lee J; Kang WK; Park JO; Park SH; Park YS; Lim HY; Kim J; Kong J; Choi MG; Sohn TS; Noh JH; Bae JM; Kim S; Lim DH; Kim KM; Park CK
APMIS; 2009 Aug; 117(8):598-606. PubMed ID: 19664131
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinical significance of claudin-4 in gastric cancer: a meta-analysis.
Liu JX; Wei ZY; Chen JS; Lu HC; Hao L; Li WJ
World J Surg Oncol; 2015 Jun; 13():207. PubMed ID: 26109060
[TBL] [Abstract][Full Text] [Related]
18. SPARCL1, a Novel Prognostic Predictive Factor for GI Malignancies: a Meta-Analysis.
Hu H; Cai W; Zheng S; Ge W
Cell Physiol Biochem; 2017; 44(4):1485-1496. PubMed ID: 29190626
[TBL] [Abstract][Full Text] [Related]
19. Correlation between p-STAT3 overexpression and prognosis in lung cancer: A systematic review and meta-analysis.
Tong M; Wang J; Jiang N; Pan H; Li D
PLoS One; 2017; 12(8):e0182282. PubMed ID: 28797050
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic significance of CD24 overexpression in patients with gastric cancer: a meta-analysis.
Wu JX; Zhao YY; Wu X; An HX
PLoS One; 2014; 9(12):e114746. PubMed ID: 25503963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]